Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > the pandemic saved TLT

<< Previous

Bullboard Posts

Next >>

Comment by Quattro74on Jul 31, 2020 8:42am

133 Views

Post# 31348496

RE:the pandemic saved TLT

riverrrow wrote: In retrospect the pandemic lockdown prevented TLT from treating even more patients and screwing up Phase II even more. Looking at all the missteps perhaps TLT should reclassify these 12 patients as Phase Ic. It's remarkable and a testament to the effectiveness of the treatment that some patients achieved CR. GLTA.

I think you are onto something there River. Covid probably caused some of this heartburn, it also certainly gave TLT time/cover to analyse what went wrong/fix it? before they had to release this data.

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions